Scopim-Ribeiro, Renata; Machado Neto, João Agostinho 
; Duarte, Adriana da Silva Santos; Costa, Fernando Ferreira; Saad, Sara Teresinha Olalla; Traina, Fabiola
Source: Applied Cancer Research. Unidade: FMRP
Subjects: LEUCEMIA, BIOMARCADORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SCOPIM-RIBEIRO, Renata et al. TET2 is upregulated during erythroid differentiation of CD34+ cells from healthy donors and myelodysplastic syndrome patients. Applied Cancer Research, v. 37, p. 4 , 2017Tradução . . Disponível em: https://doi.org/10.1186/s41241-017-0044-6. Acesso em: 13 fev. 2026.APA
Scopim-Ribeiro, R., Machado Neto, J. A., Duarte, A. da S. S., Costa, F. F., Saad, S. T. O., & Traina, F. (2017). TET2 is upregulated during erythroid differentiation of CD34+ cells from healthy donors and myelodysplastic syndrome patients. Applied Cancer Research, 37, 4 . doi:10.1186/s41241-017-0044-6NLM
Scopim-Ribeiro R, Machado Neto JA, Duarte A da SS, Costa FF, Saad STO, Traina F. TET2 is upregulated during erythroid differentiation of CD34+ cells from healthy donors and myelodysplastic syndrome patients [Internet]. Applied Cancer Research. 2017 ; 37 4 .[citado 2026 fev. 13 ] Available from: https://doi.org/10.1186/s41241-017-0044-6Vancouver
Scopim-Ribeiro R, Machado Neto JA, Duarte A da SS, Costa FF, Saad STO, Traina F. TET2 is upregulated during erythroid differentiation of CD34+ cells from healthy donors and myelodysplastic syndrome patients [Internet]. Applied Cancer Research. 2017 ; 37 4 .[citado 2026 fev. 13 ] Available from: https://doi.org/10.1186/s41241-017-0044-6
